Literature DB >> 21684616

Lesional skin in atopic dogs shows a mixed Type-1 and Type-2 immune responsiveness.

Yvette M Schlotter1, Victor P M G Rutten, Frank M Riemers, Edward F Knol, Ton Willemse.   

Abstract

Canine atopic dermatitis (AD) is a chronic inflammatory and pruritic skin disease which shares several characteristics with its human counterpart. In chronic patch test lesions of human with AD mainly a Th1-type cellular response is found. Besides, non-lesional AD skin is already skewed for inflammation and therefore different from healthy skin. The goal of this study was to characterize local immune responsiveness in chronic canine AD lesions as compared to that in non-lesional AD skin by defining T cell subset relevant cytokine- and transcription factor expression profiles. The gene expression of the Th1 cytokines IL-12p35, IL-12p40 and IFN-γ and their related transcription factors STAT4, SOCS5 and T-bet, the Th2 cytokines IL-4 and IL-13 and transcription factors STAT6, SOCS3 and GATA-3 and the regulatory cytokines IL-10 and TGF-β and the transcription factor FOXP3 was evaluated in healthy control and atopic dogs. In non-lesional (NLS) and chronic lesional skin (LS) of atopic dogs and control skin (CS) from healthy dogs mRNA expression of cytokines and transcription factors were measured by quantitative real-time PCR. Significantly different values were found for the following factors: IL-12p40 mRNA was lower in LS when compared to NLS. Expression of STAT4 was higher in LS compared to CS and NLS. More IL-13 and SOCS3 were found in LS and NLS when compared to CS and also in LS compared to NLS. GATA-3 was lower in LS compared to NLS. IL-10 expression was higher in both LS and NLS compared to CS and more IL-10 was present in LS compared to NLS. These findings indicate that both Th1- and Th2-type as well as T regulatory cells are present in NLS and LS in canine atopic skin.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684616     DOI: 10.1016/j.vetimm.2011.05.025

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  15 in total

1.  Atopic dermatitis in humans and dogs.

Authors:  Martín A Arcique; Jangi Bajwa
Journal:  Can Vet J       Date:  2020-01       Impact factor: 1.008

2.  Current Knowledge on Canine Atopic Dermatitis: Pathogenesis and Treatment.

Authors:  Catherine A Outerbridge; Tyler J M Jordan
Journal:  Adv Small Anim Care       Date:  2021-09-29

3.  Two loci on chromosome 5 are associated with serum IgE levels in Labrador retrievers.

Authors:  Marta Owczarek-Lipska; Béatrice Lauber; Vivianne Molitor; Sabrina Meury; Marcin Kierczak; Katarina Tengvall; Matthew T Webster; Vidhya Jagannathan; Yvette Schlotter; Ton Willemse; Anke Hendricks; Kerstin Bergvall; Ake Hedhammar; Göran Andersson; Kerstin Lindblad-Toh; Claude Favrot; Petra Roosje; Eliane Marti; Tosso Leeb
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

4.  Altered plasma cytokines in dogs with atopic dermatitis.

Authors:  Hamutal Mazrier; Linda J Vogelnest; Rosanne M Taylor; Peter Williamson
Journal:  Vet Dermatol       Date:  2021-11-24       Impact factor: 1.867

5.  Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis.

Authors:  Alicja Majewska; Małgorzata Gajewska; Kourou Dembele; Henryk Maciejewski; Adam Prostek; Michał Jank
Journal:  BMC Vet Res       Date:  2016-08-23       Impact factor: 2.741

6.  A study on periostin involvement in the pathophysiology of canine atopic skin.

Authors:  Takayuki Mineshige; Junichi Kamiie; Go Sugahara; Kinji Shirota
Journal:  J Vet Med Sci       Date:  2017-11-27       Impact factor: 1.267

Review 7.  Atopic dermatitis in cats and dogs: a difficult disease for animals and owners.

Authors:  Natalie Katharina Yvonne Gedon; Ralf Steffen Mueller
Journal:  Clin Transl Allergy       Date:  2018-10-05       Impact factor: 5.871

8.  Expression of barrier proteins in the skin lesions and inflammatory cytokines in peripheral blood mononuclear cells of atopic dogs.

Authors:  Sarita Kanwal; Shanker K Singh; Sandeep P Soman; Soumen Choudhury; Priyambada Kumari; Pradeep K Ram; Satish K Garg
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

9.  Oclacitinib (APOQUEL(®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy.

Authors:  A J Gonzales; J W Bowman; G J Fici; M Zhang; D W Mann; M Mitton-Fry
Journal:  J Vet Pharmacol Ther       Date:  2014-02-05       Impact factor: 1.786

Review 10.  Companion Animals as Models for Inhibition of STAT3 and STAT5.

Authors:  Matthias Kieslinger; Alexander Swoboda; Nina Kramer; Barbara Pratscher; Birgitt Wolfesberger; Iwan A Burgener
Journal:  Cancers (Basel)       Date:  2019-12-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.